Genitrix launches new canine epilepsy treatment
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy. Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the...
As a member, you can connect with other vets, get full access to our comprehensive diary for the profession, advertise and browse jobs for veterinary surgeons, participate in various special interest groups and associations, and much more...